Decreased EPAS1 messenger RNA (mRNA) expression (with no copy number variation) was detected in the majority of STS patient samples analysed, including UPS, fibrosarcoma and liposarcoma. This evidence concerns the gene EPAS1 and undifferentiated pleomorphic sarcoma.